Publication | Closed Access

Pilot trial of intravenous infusion of a replication-selective adenovirus (ONYX-015) in combination with chemotherapy or IL-2 treatment in refractory cancer patients

Replication-selective AdenovirusRefractory Cancer PatientsMedicineImmunologyIl-2 TreatmentCancer TreatmentOncologyViral OncologyCancer ResearchCancer-associated Virus